Watching the latest court rulings in the coronary-stent patent infringement suits brought by Boston Scientific Corp. (Natick, MA) and Cordis Corp. (Miami Lakes, FL), a Johnson & Johnson company, is a ...

CHICAGO, April 20 (Reuters) - Boston Scientific Corp posted a quarterly net loss on Monday after taking a large charge related to a negative ruling in a stent patent lawsuit. Excluding one-time items, ...

WASHINGTON — Boston Scientific Corp on Wednesday reported data showing that its drug-coated stents are no more dangerous than older bare-metal stents for patients who have just suffered a major heart ...

CHICAGO, April 24 (Reuters) - Analysts cut sales and profit forecasts for Boston Scientific Corp. on Tuesday after the medical device maker posted first-quarter results that underscored the challenges ...

Boston Scientific Corp. (NYSE:BSX) officials said today that renewed strength in its drug-eluting stent business should be enough to offset a weak cardiac rhythm management market over the near term.

Natick, MA – Boston Scientific Corporation’s WallFlex® Biliary RX Fully Covered Stent has received Health Canada approval for the treatment of benign biliary strictures, which supplements its current ...

BOSTON (CBS.MW) -- Boston Scientific announced Friday afternoon that it was recalling 96,000 of its coronary artery stent systems because they are believed to be linked to three patient deaths and 43 ...

Boston Scientific has launched a new app, called the Ureteral Stent Tracker, that helps urologists and their staff keep tabs on ureteral stents implanted in patients with kidney stones. The app was ...

Natick, Mass.-based medical device giant Boston Scientific Corp. hits one of the world’s fastest-growing markets with two of its drug-eluting stents, Promus and Taxus. Boston Scientific Corp.